Novartis, feeling the heat from head-to-head rivals, pulls Arzerra outside the U.S.

22nd January 2018 Uncategorised 0

The commercial life for Novartis’ Arzerra outside the U.S. is coming to an end. On Monday, Novartis partner Genmab said the Swiss drugmaker would pull the chronic lymphocytic leukemia product from all ex-U.S. markets and set up compassionate use programs to allow current patients to continue treatment.

More: Novartis, feeling the heat from head-to-head rivals, pulls Arzerra outside the U.S.
Source: fierce